A citation-based method for searching scientific literature

B Zambrowicz, J Freiman, P M Brown, K S Frazier, A Turnage, J Bronner, D Ruff, M Shadoan, P Banks, F Mseeh, D B Rawlins, N C Goodwin, R Mabon, B A Harrison, A Wilson, A Sands, D R Powell. Clin. Pharmacol. Ther. 2012
Times Cited: 137



Ele Ferrannini, Elza Muscelli, Silvia Frascerra, Simona Baldi, Andrea Mari, Tim Heise, Uli C Broedl, Hans-Juergen Woerle. J. Clin. Invest. 2014
Times Cited: 496




List of shared articles



Times cited

SGLT1 inhibition boon or bane for diabetes-associated cardiomyopathy.
Jaspreet Kalra, Suresh Babu Mangali, Deepika Dasari, Audesh Bhat, Srashti Goyal, Indu Dhar, Dharamrajan Sriram, Arti Dhar. Fundam Clin Pharmacol 2020
1

Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption.
David R Powell, Brian Zambrowicz, Linda Morrow, Carine Beysen, Marcus Hompesch, Scott Turner, Marc Hellerstein, Phillip Banks, Paul Strumph, Pablo Lapuerta. J. Clin. Endocrinol. Metab. 2020
0

SGLT2 is not expressed in pancreatic α- and β-cells, and its inhibition does not directly affect glucagon and insulin secretion in rodents and humans.
Heeyoung Chae, Robert Augustin, Eva Gatineau, Eric Mayoux, Mohammed Bensellam, Nancy Antoine, Firas Khattab, Bao-Khanh Lai, Davide Brusa, Birgit Stierstorfer,[...]. Mol Metab 2020
0

Pharmacological evaluation of HM41322, a novel SGLT1/2 dual inhibitor, in vitro and in vivo.
Kyu Hang Lee, Sang Don Lee, Namdu Kim, Kwee Hyun Suh, Young Hoon Kim, Sang Soo Sim.  2019
1

Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives.
Chiara Maria Assunta Cefalo, Francesca Cinti, Simona Moffa, Flavia Impronta, Gian Pio Sorice, Teresa Mezza, Alfredo Pontecorvi, Andrea Giaccari. Cardiovasc Diabetol 2019
18

What does sodium-glucose co-transporter 1 inhibition add: Prospects for dual inhibition.
Jessica A Dominguez Rieg, Timo Rieg. Diabetes Obes Metab 2019
5

Ion channels and transporters in diabetic kidney disease.
Denisha Spires, Anna D Manis, Alexander Staruschenko. Curr Top Membr 2019
5

Concurrent Use of Teneligliptin and Canagliflozin Improves Glycemic Control with Beneficial Effects on Plasma Glucagon and Glucagon-Like Peptide-1: A Single-Arm Study.
Tomoho Noda, Emi Ebihara, Hiroaki Ueno, Keisuke Sadohara, Yuri Tanaka, Yuuma Nagatomo, Yousuke Murakami, Shinichi Yonamine, Wakaba Tsuchimochi, Hideyuki Sakoda,[...]. Diabetes Ther 2019
1


Short-term effects of dapagliflozin on insulin sensitivity, postprandial glucose excursion and ketogenesis in type 1 diabetes mellitus: A randomized, placebo-controlled, double blind, cross-over pilot study.
Andreas Melmer, Patrick Kempf, Lukas Lunger, Thomas R Pieber, Julia K Mader, Christoph Stettler, Herbert Tilg, Christoph F Ebenbichler, Markus Laimer. Diabetes Obes Metab 2018
0




Energy balance and metabolic changes with sodium-glucose co-transporter 2 inhibition.
S P Rajeev, D J Cuthbertson, J P H Wilding. Diabetes Obes Metab 2016
32

Metabolic consequences of acute and chronic empagliflozin administration in treatment-naive and metformin pretreated patients with type 2 diabetes.
Elza Muscelli, Brenno Astiarraga, Elisabetta Barsotti, Andrea Mari, Freimut Schliess, Leszek Nosek, Tim Heise, Uli C Broedl, Hans-Juergen Woerle, Ele Ferrannini. Diabetologia 2016
9

Sodium glucose transport modulation in type 2 diabetes and gastric bypass surgery.
Gregory Baud, Violeta Raverdy, Caroline Bonner, Mehdi Daoudi, Robert Caiazzo, François Pattou. Surg Obes Relat Dis 2016
7



Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes.
David R Powell, Deon Doree, Sabrina Jeter-Jones, Zhi-Ming Ding, Brian Zambrowicz, Arthur Sands.  2015
13

LP-925219 maximizes urinary glucose excretion in mice by inhibiting both renal SGLT1 and SGLT2.
David R Powell, Melinda G Smith, Deon D Doree, Angela L Harris, Wendy W Xiong, Faika Mseeh, Alan Wilson, Suma Gopinathan, Damaris Diaz, Nicole C Goodwin,[...]. Pharmacol Res Perspect 2015
7

SLC transporters as therapeutic targets: emerging opportunities.
Lawrence Lin, Sook Wah Yee, Richard B Kim, Kathleen M Giacomini. Nat Rev Drug Discov 2015
180

Sodium glucose co-transporter inhibitors for the management of diabetes mellitus: an opinion paper from the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy.
Jennifer N Clements, Heather P Whitley, Jennifer J D'Souza, Benjamin Gross, Rick Hess, Sara Reece, Chad Gentry, Kayce Shealy. Curr Med Res Opin 2015
1

Sodium-Glucose Cotransporter Inhibitors: Effects on Renal and Intestinal Glucose Transport: From Bench to Bedside.
Sunder Mudaliar, David Polidori, Brian Zambrowicz, Robert R Henry. Diabetes Care 2015
97